192 related articles for article (PubMed ID: 21130668)
1. Moyamoya syndrome associated with Graves' disease: a case report and review of the literature.
Malik S; Russman AN; Katramados AM; Silver B; Mitsias PD
J Stroke Cerebrovasc Dis; 2011 Nov; 20(6):528-36. PubMed ID: 21130668
[TBL] [Abstract][Full Text] [Related]
2. Moyamoya disease complicated by Graves' disease and type 2 diabetes mellitus: report of two cases.
Suzuki S; Mitsuyama T; Horiba A; Fukushima S; Hashimoto N; Kawamata T
Clin Neurol Neurosurg; 2011 May; 113(4):325-9. PubMed ID: 21215511
[TBL] [Abstract][Full Text] [Related]
3. Neurologic improvement without angiographic improvement after antithyroid therapy in a patient with Moyamoya syndrome.
Ishigami A; Toyoda K; Suzuki R; Miyashita F; Iihara K; Minematsu K
J Stroke Cerebrovasc Dis; 2014; 23(5):1256-8. PubMed ID: 24119625
[TBL] [Abstract][Full Text] [Related]
4. Concurrent Graves' disease and intracranial arterial stenosis/occlusion: special considerations regarding the state of thyroid function, etiology, and treatment.
Ohba S; Nakagawa T; Murakami H
Neurosurg Rev; 2011 Jul; 34(3):297-304; discussion 304. PubMed ID: 21424208
[TBL] [Abstract][Full Text] [Related]
5. Moyamoya Disease Associated with Graves' Disease and Down Syndrome: A Case Report and Literature Review.
Nakamura H; Sato K; Yoshimura S; Hayashi Y; Izumo T; Tokunaga Y
J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105414. PubMed ID: 33130479
[TBL] [Abstract][Full Text] [Related]
6. Concurrent moyamoya disease and Graves' thyrotoxicosis: case report and literature review.
Shen AL; Ryu SJ; Lin SK
Acta Neurol Taiwan; 2006 Jun; 15(2):114-9. PubMed ID: 16871899
[TBL] [Abstract][Full Text] [Related]
7. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
Hayashi T; Shirane R; Fujimura M; Tominaga T
J Neurosurg Pediatr; 2010 Jul; 6(1):73-81. PubMed ID: 20593991
[TBL] [Abstract][Full Text] [Related]
8. Familial moyamoya disease associated with Graves' disease in a mother and daughter. Two case reports.
Tokimura H; Tajitsu K; Takashima H; Hirayama T; Tsuchiya M; Takayama K; Arita K
Neurol Med Chir (Tokyo); 2010; 50(8):668-74. PubMed ID: 20805652
[TBL] [Abstract][Full Text] [Related]
9. Coexistence of moyamoya and Graves' diseases: the clinical characteristics and treatment effects of 21 Chinese patients.
Li D; Yang W; Xian P; Liu P; Bao X; Zong R; Duan L
Clin Neurol Neurosurg; 2013 Sep; 115(9):1647-52. PubMed ID: 23518423
[TBL] [Abstract][Full Text] [Related]
10. Graves' disease in children and adolescents: response to long-term treatment.
Barrio R; López-Capapé M; Martinez-Badás I; Carrillo A; Moreno JC; Alonso M
Acta Paediatr; 2005 Nov; 94(11):1583-9. PubMed ID: 16303698
[TBL] [Abstract][Full Text] [Related]
11. Perfusion-weighted magnetic resonance imaging in adult moyamoya syndrome: characteristic patterns and change after surgical intervention: case report.
Wityk RJ; Hillis A; Beauchamp N; Barker PB; Rigamonti D
Neurosurgery; 2002 Dec; 51(6):1499-505; discussion 1506. PubMed ID: 12445358
[TBL] [Abstract][Full Text] [Related]
12. [The surgical treatment of Graves' disease].
de Ruijter SH; van Dalen T; Muller AF
Ned Tijdschr Geneeskd; 2006 Jun; 150(24):1321-5. PubMed ID: 16808361
[TBL] [Abstract][Full Text] [Related]
13. Concurrence of Graves' disease and dysplastic cerebral blood vessels of the moyamoya variety.
Tendler BE; Shoukri K; Malchoff C; MacGillivray D; Duckrow R; Talmadge T; Ramsby GR
Thyroid; 1997 Aug; 7(4):625-9. PubMed ID: 9292953
[TBL] [Abstract][Full Text] [Related]
14. A 10-year-old girl with coexistent moyamoya disease and Graves' disease.
Golomb MR; Biller J; Smith JL; Edwards-Brown M; Sanchez JC; Nebesio TD; Garg BP
J Child Neurol; 2005 Jul; 20(7):620-4. PubMed ID: 16159534
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcome of Graves' disease in Thai children.
Somnuke PH; Pusuwan P; Likitmaskul S; Santiprabhob J; Sawathiparnich P
J Med Assoc Thai; 2007 Sep; 90(9):1815-20. PubMed ID: 17957924
[TBL] [Abstract][Full Text] [Related]
16. Moyamoya disease associated with Graves disease: special considerations regarding clinical significance and management.
Im SH; Oh CW; Kwon OK; Kim JE; Han DH
J Neurosurg; 2005 Jun; 102(6):1013-7. PubMed ID: 16028759
[TBL] [Abstract][Full Text] [Related]
17. Hyperthyroidism: diagnosis and management of Graves' disease.
Schilling JS
Nurse Pract; 1997 Jun; 22(6):72, 75, 78 passim; quiz 96-7. PubMed ID: 9211454
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic Moyamoya disease: clinical features and outcome after indirect bypass surgery in four French adults.
Derex L; Doumbé J; Kouamé-Assouan AE; Pelissou-Guyotat I; Morel C; Hermier M; Nighoghossian N; Trouillas P
J Neurol Sci; 2010 Jan; 288(1-2):92-5. PubMed ID: 19840882
[TBL] [Abstract][Full Text] [Related]
19. Moyamoya syndrome with protein S deficiency.
Akgün D; YiLmaz S; Senbil N; Aslan B; Gürer YY
Eur J Paediatr Neurol; 2000; 4(4):185-8. PubMed ID: 11008263
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
Antonelli A; Fallahi P; Rotondi M; Ferrari SM; Serio M; Miccoli P
Br J Surg; 2006 Oct; 93(10):1226-31. PubMed ID: 16838393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
